Cargando…

High expression COL10A1 promotes breast cancer progression and predicts poor prognosis

BACKGROUND: As a common malignant disease in females, breast cancer (BCa) causes increasing numbers of cancer-related death. Collagen X alpha 1 chain (COL10A1) plays a critical role in the oncogenesis and progression of malignant tumors. However, a systematic analysis of COL10A1 in BCa has not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Weijian, Li, Yuting, Gu, Dingyi, Xu, Junying, Wang, Runjie, Wang, Huiyu, Liu, Chaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586897/ https://www.ncbi.nlm.nih.gov/pubmed/36281404 http://dx.doi.org/10.1016/j.heliyon.2022.e11083

Ejemplares similares

HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome
por: He, Xiaoting, et al.
Publicado: (2023)

A comparability study of natural and deglycosylated PD-L1 levels in lung cancer: evidence from immunohistochemical analysis
por: Mei, Jie, et al.
Publicado: (2021)

Evaluation of X-Ray Repair Cross-Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma
por: Mei, Jie, et al.
Publicado: (2020)

NY-ESO-1 expression in solid tumors predicts prognosis: A systematic review and meta-analysis
por: Wang, Huiyu, et al.
Publicado: (2019)

High-dose fulvestrant as third-line endocrine therapy for breast cancer metastasis to the left kidney: A case report and literature review
por: Xia, Dandan, et al.
Publicado: (2018)

Systematic summarization of the expression profiles and prognostic roles of the dishevelled gene family in hepatocellular carcinoma
por: Mei, Jie, et al.
Publicado: (2020)

High expression of COL10A1 is associated with poor prognosis in colorectal cancer
por: Huang, Haipeng, et al.
Publicado: (2018)

COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer
por: Owusu-Ansah, Kwabena Gyabaah, et al.
Publicado: (2019)

Predictions for high COL1A1 and COL10A1 expression resulting in a poor prognosis in esophageal squamous cell carcinoma by bioinformatics analyses
por: Li, Yang, et al.
Publicado: (2020)

Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma
por: Mei, Jie, et al.
Publicado: (2019)

High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma
por: Mao, Feiyu, et al.
Publicado: (2020)

GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC
por: Fan, Honghong, et al.
Publicado: (2023)

The Clinical Significance of Deglycosylated PD-L1 Level Detection Using 28-8 Monoclonal Antibody in Lung Adenocarcinoma
por: Wang, Huiyu, et al.
Publicado: (2022)

The emerging roles of circular RNAs in ovarian cancer
por: Yang, Xuejing, et al.
Publicado: (2020)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer
por: Zhang, Xuezhou, et al.
Publicado: (2022)

Microfluidic devices: The application in TME modeling and the potential in immunotherapy optimization
por: Li, Yuting, et al.
Publicado: (2022)

RAB10 promotes breast cancer proliferation migration and invasion predicting a poor prognosis for breast cancer
por: Zhuo, Jian, et al.
Publicado: (2023)

GABRD promotes progression and predicts poor prognosis in colorectal cancer
por: Niu, Gengming, et al.
Publicado: (2020)

Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)

Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis
por: Dai, Da-nian, et al.
Publicado: (2017)

Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer
por: Elsharawy, Khloud A., et al.
Publicado: (2020)

NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signature
por: Jiang, Zhiyang, et al.
Publicado: (2022)

COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma
por: Wang, Hongbo, et al.
Publicado: (2021)

COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer
por: Luo, Qi, et al.
Publicado: (2022)

COL3A1 Overexpression Associates with Poor Prognosis and Cisplatin Resistance in Lung Cancer
por: Wang, Lihuai, et al.
Publicado: (2022)

Increased Collagen Type V α2 (COL5A2) in Colorectal Cancer is Associated with Poor Prognosis and Tumor Progression
por: Wang, Jie, et al.
Publicado: (2021)

MIR31HG Expression Predicts Poor Prognosis and Promotes Colorectal Cancer Progression
por: Wang, Jianlong, et al.
Publicado: (2022)

KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer
por: Li, Zhongjun, et al.
Publicado: (2020)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

DLX5 promotes Col10a1 expression and chondrocyte hypertrophy and is involved in osteoarthritis progression
por: Chen, Jinnan, et al.
Publicado: (2023)

Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma
por: Liang, Yingkuan, et al.
Publicado: (2020)

Upregulation of COL8A1 indicates poor prognosis across human cancer types and promotes the proliferation of gastric cancer cells
por: Zhou, Jun, et al.
Publicado: (2020)

Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
por: Cui, Yifeng, et al.
Publicado: (2019)

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer
por: Zhang, Xiao‐Guang, et al.
Publicado: (2018)

Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2018)

COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma
por: Xu, Qiaodong, et al.
Publicado: (2023)

ME1 promotes basal-like breast cancer progression and associates with poor prognosis
por: Liao, Ruocen, et al.
Publicado: (2018)

Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer
por: Liu, Qi, et al.
Publicado: (2022)

Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation
por: Lin, Hong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oqpijl169o9l64p8oa3hvhbsl9